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INTRODUCTION
Acute chest syndrome (ACS) is a severe pulmonary 
complication in pregnant women with sickle cell disease 
(SCD).1-3 Between January 1998 and December 2002, ACS 
occurred in 4 of 286 pregnant women with SCD in Bahrain 
(1.2%), and it was associated with two maternal deaths.4 
In the United States, 10 pregnant women (0.06%) were 
diagnosed with ACS out of 17,952 deliveries in women 
with SCD from 2000 to 2003.5 ACS has been attributed to 
pulmonary vasoocclusion and fat emboli originated from 
bone marrow infarctions with subsequent hypoventilation. 
Infectious etiology has also been considered. 
The pregnancy outcome for patients with hemoglobin 
SC disease has been reported to be good to optimal when 
compared to the outcome of those with homozygous 
hemoglobin S (Hb SS).6 Although most SC patients are 
mildly affected by clinical events, some of them develop 
severe complications. We report two cases of severe ACS 
in pregnant women with hemoglobin SC disease, including 
maternal and perinatal outcome.
CASE DESCRIPTIONS
Case 1: A 26-year-old woman, para 1, with hemoglobin 
SC disease and no prior history of ACS, was admitted at 
32 weeks’ gestation with preeclampsia and fetal growth 
restriction. At the gestational age of 32 5/7 weeks, she 
presented with sudden onset of hypertonic uterus, abdominal 
discomfort, hypotension, and shortness of breath (oxygen 
saturation 90%). An emergency cesarean was performed. 
Placental abruption was detected, and a stillborn weighing 
1,630 g was delivered. The laboratory test results showed 
hemoglobin electrophoresis of S 51%, C 47.5%, and 
F 1.5%, hemoglobin 8.4 g/dL, white blood cell count 
(WBCC) 34.3x109/L, platelet count 142,000/mm3, alanine 
aminotransferase (ALT) 35 U/L, aspartate aminotransferase 
(AST) 54 U/L, total bilirubin 1.5 mg/dL, and lactate 
dehydrogenase (LDH) 791 U/L. The patient was transferred 
to the ICU immediately post-cesarean, where examination 
revealed that the uterus was contracted and without abnormal 
bleeding. At the fifth hour post-partum, she presented with 
bradycardia and hypotension. An intravenous infusion 
of vasoactive drugs and broad-spectrum antibiotics were 
administered. A red blood cell transfusion was performed. 
At the eighth hour post-partum, she was hemodynamically 
unstable, and echocardiography was used to diagnose diffuse 
hypokinesis of the right ventricle with dilatation of the right 
chambers. At the tenth hour post-cesarean, she presented 
with cardiovascular shock, bradycardia, hypotension, and 
cardiac arrest. The autopsy revealed bone marrow pulmonary 
emboli.
Case 2: A 29-year-old woman, primigravida, with 
hemoglobin SC disease and no prior history of ACS, 
was admitted at 32 6/7 weeks with vasoocclusive crisis. 
Oxygen therapy, pain management, and intravenous fluids 
were provided. The laboratory tests showed hemoglobin 
electrophoresis of S 48.8%, C 50.3%, and F 0.9%, 
hemoglobin 9.2 g/dL, WBCC 17.6x109/L, platelet count 
242,000/mm3, ALT 29 U/L, AST 45 U/L, total bilirubin 
2.05 mg/dL, and LDH 1325 U/L. At 33 weeks of gestation, 
the patient presented with sudden onset of dizziness and 
hypoxemia (oxygen saturation 78% on room air). Her blood 
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pressure was 140/90 mmHg, heart rate 110 bpm, respiratory 
rate 40 per minute, and temperature 37.2°C. Her heart 
sounds were normal, and pulmonary sounds were reduced 
on lung bases bilaterally. Broad-spectrum antibiotics were 
administered. A chest X-ray revealed no abnormalities. 
Cardiotocography showed fetal tachycardia and repeated 
late decelerations. Fetal distress was diagnosed. At this time, 
the maternal hemoglobin level was 6.3 g/dL. Two packs 
of red blood cells were transfused prior to the emergency 
cesarean. A small-for-gestational-age male infant was born, 
weighing 2,020 g, with Apgar scores of 1, 6, and 8 at 1, 5, 
and 10 minutes, respectively. After the cesarean, the patient 
was transferred to the ICU and received 3 more units of red 
blood cell concentrate. She was discharged from the hospital 
10 days postpartum, and the newborn was alive and well.
DISCUSSION
ACS is an important cause of maternal morbidity 
and mortality, leading to hospital admission of pregnant 
women with SCD. Early identification of ACS is highly 
desirable, particularly in pregnant women with SCD. 
Aggressive treatment and red blood cells transfusions 
should be instituted before childbirth in order to prevent 
an adverse outcome for both mother and infant. Maternal 
acute hypoxemia leads to fetal distress and adverse perinatal 
outcome. During pregnancy, ACS has been described as 
presenting favorable maternal and neonatal outcomes.5 
Recently, ACS during pregnancy has been reported as the 
initial manifestation of SCD.7
The clinical presentation of ACS depends on etiological 
factors; however, it is not identifiable in almost 46% of 
cases.2 If the clinical course of the respiratory failure in those 
patients is not clear, with a worsening of hypoxia and rapid 
deterioration of the clinical condition, pulmonary embolism 
should be considered. Treatment would require the use of 
antibiotics, oxygen therapy, pain control, administration 
of IV fluids, and red blood cell transfusion or exchange 
transfusion. The decision-making process with regard to the 
use of red blood cell or an exchange transfusion should be 
based upon the severity of maternal and fetal compromise. 
An early red blood cell transfusion may increase the oxygen-
carrying capacity and improve pulmonary function in 
pregnant patients with ACS prior to cesarean delivery.
Female patients with SC disease may present with 
complications at any time over the course of the pregnancy, 
labor and delivery, or post-partum. Prompt recognition of 
severe respiratory failure is required to provide the intensive 
treatment needed to improve maternal-fetal outcomes. 
Obstetricians must work closely with hematologists in order 
to prevent maternal death in cases of ACS during pregnancy.
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